Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 116Unknown 68Active not recruiting 25Terminated 23Recruiting 16Withdrawn 5Not yet recruiting 2Suspended 1Enrolling by invitation 1

Sponsor Class

OTHER 200INDUSTRY 28OTHER_GOV 5NIH 2FED 2NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2Genitourinary 1Breast 1

Conditions

Leukemia, Myeloid, Acute 4Carcinoma, Non-Small-Cell Lung 3Prostatic Neoplasms 2Neoplasms 2Multiple Myeloma 2Lung Neoplasms 2Breast Neoplasms 2Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Small Cell Lung Carcinoma 1Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma 1Recurrence 1Pulmonary Blastoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Plasmablastic Lymphoma 1Pancreatic Neoplasms 1Pain, Intractable 1Neuroblastoma 1Neoplasms, Glandular and Epithelial 1Neoplasms by Histologic Type 1Myelodysplastic Syndromes 1Melanoma, Cutaneous Malignant 1Melanoma 1Lymphoma 1Li-Fraumeni Syndrome 1Leukemia, Plasma Cell 1Leukemia 1Legius syndrome 1Hematologic Neoplasms 1Gliosarcoma 1

Interventions

Specimen Handling 2sargramostim 1montanide ISA 51 1X-Rays 1Technetium 1Photons 1Pentetic Acid 1Magnetic Resonance Spectroscopy 1Glutamate Carboxypeptidase II 1Colony-Stimulating Factors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × NIH × Lung Neoplasms × Clear all
NCT07169617 2026-06-03

Testing the SurVaxM Vaccine for Lung Cancer Prevention

National Cancer Institute (NCI)

Phase 2 Not yet recruiting
80 enrolled
Thoracic

Lung Neoplasms

NCT06982222 2026-05-13

Testing the Safety of the Anti-cancer Drug, Sn-117m-DTPA, for Advanced Cancers That Have Spread to Bones

National Cancer Institute (NCI)

Phase 1 Not yet recruiting
24 enrolled
BreastGenitourinaryThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡